Effect of lipoic acid and α-glyceryl-phosphoryl-choline on astroglial cell proliferation and differentiation in primary culture

Journal of Neuroscience Research

Volumn 92, Issue 1, 2014, Pages 86-94

  Grasso, S ^a   Bramanti, V ^a   Tomassoni, D ^b   Bronzi, D ^a   Malfa, G ^a   Traini, E ^a,b   Napoli, M ^a   Renis, M ^a   Amenta, F ^b   Avola, R ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b UNIVERSITY OF CAMERINO   (Italy)

Author keywords

lipoic acid; GPC; Astroglial cell cultures; Cyclin D1; Cytoskeletal proteins; MAP kinase

Indexed keywords

BIOLOGICAL MARKER; CHOLINE ALFOSCERATE; CYCLIN D1; DNA; MITOGEN ACTIVATED PROTEIN KINASE; ORNITHINE DECARBOXYLASE; THIOCTIC ACID; VIMENTIN;

ANIMAL CELL; ARTICLE; ASTROCYTE; ASTROCYTE CULTURE; CELL PROLIFERATION; COMET ASSAY; CONTROLLED STUDY; ENANTIOMER; NERVE CELL DIFFERENTIATION; NONHUMAN; OXIDATIVE STRESS; PRIMARY CELL CULTURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ASTROGLIAL CELL CULTURES; CYCLIN D1; CYTOSKELETAL PROTEINS; MAP-KINASE; Α-LIPOIC ACID; ΑGPC;

ANIMALS; ASTROCYTES; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; GLYCERYLPHOSPHORYLCHOLINE; RATS; RATS, WISTAR; THIOCTIC ACID;

EID: 84888068341     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.23289     Document Type: Article

References (31)

1. Amenta F, Tayebati SK. 2008. Pathways of acetylcholine synthesis, transport and release as targets for treatment of adult-onset cognitive dysfunction. Curr Med Chem 15:488-498. doi: 10.2174/092986708783503203.
2. Amenta F, Liu A, Zeng YC, Zaccheo D. 1994. Muscarinic cholinergic receptors in the hippocampus of aged rats: influence of choline alphoscerate treatment. Mech Ageing Dev 76:49-64. doi: 10.1016/0047-6374(94)90007-8.
3. Amenta F, Parnetti L, Gallai V, Wallin A. 2001. Treatment of cognitive dysfunction associated with Alzheimer's disease with cholinergic precursors. Ineffective treatments or inappropriate approaches? Mech Ageing Dev 122:2025-2040. doi: 10.1016/S0047-6374(01)00310-4.
4. Bramanti V, Campisi A, Tomassoni D, et al. 2007. Astroglial-conditioned media and growth factors modulate proliferation and differentiation of astrocytes in primary culture. Neurochem Res 32:49-56. doi: 10.1007/s11064-006-9224-6.
5. Bramanti V, Bronzi D, Tomassoni D, et al. 2008a. Effect of choline-containing phospholipids on transglutaminase activity in primary astroglial cell cultures. Clin Exp Hypertens 30:798-807. doi: 10.1080/10641960802563576.
6. Bramanti V, Bronzi D, Tomassoni D, et al. 2008b. Growth factors and steroid mediated regulation of cytoskeletal protein expression in serum-deprived primary astrocyte cultures. Neurochem Res 33:2593-600. doi: 10.1007/s11064-008-9767-9.
7. Bramanti V, Campisi A, Tomassoni D, et al. 2008c. Effect of acetylcholine precursors on proliferation and differentiation of astroglial cells in primary cultures. Neurochem Res 33:2601-2608. doi: 10.1007/s11064-008-9829-z.
8. Bramanti V, Tomassoni D, Avitabile M, et al. 2010a. Biomarkers of glial cell proliferation and differentiation in culture. Front Biosci 2:558-570. doi: 10.2741/s85.
9. Bramanti V, Tomassoni D, Bronzi D, et al. 2010b. α-Lipoic acid modulates GFAP, vimentin, nestin, cyclin D1 and MAP-kinase expression in astroglial cell cultures. Neurochem Res 35:2070-2077. doi: 10.1007/s11064-010-0256-6.
10. Bramanti V, Grasso S, Bronzi D, et al. 2012. Cholinergic precursors modulate the expression of heme oxigenase-1, p21 during astroglial cell proliferation and differentiation in culture. Neurochem Res 37:2795-2804. doi: 10.1007/s11064-012-0873-3.
11. Bronzi D, Bramanti V, Tomassoni D, et al. 2010. Neural markers expression in rat bone marrow mesenchymal stem cell cultures treated with neurosteroids. Neurochem Res 35:2154-2160. doi: 10.1007/s11064-010-0283-3.
12. Campisi A, Bramanti V, Caccamo D, et al. 2008. Effect of growth factors and steroids on transglutaminase activity and expression in primary astroglial cell cultures. J Neurosci Res 86:1297-1305. doi: 10.1002/jnr.21579.
13. Estrada DE, Ewart HS, Tsakiridis T, et al. 1996. Stimulation of glucose uptake by the natural coenzyme α-lipoic acid/thioctic acid: participation of elements of the insulin signaling pathway. Diabetes 45:1798-1804. doi: 10.2337/diabetes.45.12.1798.
14. Evans JL, Goldfine ID. 2000. α-Lipoic acid: a multifunctional antioxidant that improves insulin sensitivity in patients with type 2 diabetes. Diabetes Technol Ther 2:401-413. doi: 10.1089/15209150050194279.
15. Gottfries CG, Blennow K, Karlsson I, Wallin A. 1994. The neurochemistry of vascular dementia. Dementia 5:163-167.
16. Harrison BC, Mobley PL. 1992. Phosphorylation of glial fibrillary acidic protein and vimentin by cytoskeletal-associated intermediate filament protein kinase activity in astrocytes. J Neurochem 58:320-327. doi: 10.1111/j.1471-4159.1992.tb09313.x.
17. Jones W, Li X, Qu ZC, et al. 2002. Uptake, recycling, and antioxidant actions of α-lipoic acid in endothelial cells. Free Radic Biol Med 33:83-93. doi: 10.1016/S0891-5849(02)00862-6.
18. Khanna S, Roy S, Packer L, et al. 1999. Cytokine-induced glucose uptake in skeletal muscle: redox regulation and the role of α-lipoic acid. Am J Physiol 276:R1327-R1333.
19. Kramer K, Packer L, Hoppe P. 2001. R-α-lipoic acid. nutraceuticals in health and disease prevention. New York: Marcel Dekker. p 129-164.
20. Muccioli G, Raso GM, Ghé C, Di Carlo R. 1996. Effect of L-α glycerylphosphorylcholine on muscarinic receptors and membrane microviscosity of aged rat brain. Prog Neuropsychopharmacol Biol Psychiatry 20:323-339. doi: 10.1016/0278-5846(95)00313-4.
21. Muller U, Krieglstein J. 1995. Prolonged pre-treatment with α-lipoic acid protects cultured neurons against hypoxic, glutamate-, or iron-induced injury. J Cereb Blood Flow Metab 15:624-630. doi: 10.1038/jcbfm.1995.77.
22. Ou P, Tritschler HJ, Wolff SP. 1995. Thioctic (lipoic) acid: a therapeutic metal-chelating antioxidant? Biochem Pharmacol 50:123-126. doi: 10.1016/0006-2952(95)00116-H.
23. Packer L, Witt EH, Tritschler HJ. 1995. α-Lipoic acid as a biological antioxidant. Free Radic Biol Med 19:227-250. doi: 10.1016/0891-5849(95)00017-R.
24. Packer L, Tritschler HJ, Wessel K. 1997. Neuroprotection by the metabolic antioxidant α-lipoic acid. Free Radic Biol Med 22:359-378. doi: 10.1016/S0891-5849(96)00269-9.
25. Parnetti L, Mignini F, et al. 2007. Cholinergic precursors in the treatment of cognitive impairment of vascular origin: ineffective approaches or need for re-evaluation? J Neurol Sci 257:264-269. doi: 10.1016/j.jns.2007.01.043.
26. Prezzavento O, Campisi A, Ronsisvalle S, et al. 2007. Novel sigma receptor ligands: synthesis and biological profile. J Med Chem 50:951-961. doi: 10.1021/jm0611197.
27. Reed LJ. 2001. A trail of research from lipoic acid to α-keto acid dehydrogenase complexes. J Biol Chem 276:38329-38336. doi: 10.1074/jbc.R100026200.
28. Salinthone S, Yadav VN, Bourdette D, et al. 2008. Lipoic acid: a novel therapeutic approach for multiple sclerosis and other chronic inflammatory diseases of the CNS. Endocrine Metab Immune Disord Drug Targets 8:132-142. doi: 10.2174/187153008784534303.
29. Smith AR, Shenvi SV, Widlansky M, et al. 2004. Lipoic acid as a potential therapy for chronic diseases associated with oxidative stress. Curr Med Chem 11:1135-1146. doi: 10.2174/0929867043365387.
30. Tayebati SK, Amenta F. 2013. Choline-containing phospholipids: relevance to brain functional pathways. Clin Chem Lab Med 51:513-521. doi: 10.1515/cclm-2012-0559.
31. Tomassoni D, Bramanti V, Amenta F. 2010. Expression of aquaporins 1 and 4 in the brain of spontaneously hypertensive rats. Brain Res.1325:155-163. doi: 10.1016/j.brainres.2010.02.023.